Advertisement

Topics

Translational Drug Development (TD2) and Minneamrita Therapeutics LLC Company Profile

18:41 EST 19th January 2019 | BioPortfolio

Minneamrita is an early clinical stage drug development company developing the molecules for unmet cancer treatments. Minneamrita is developing Minnelide for its use in various cancers (gastric, pancreatic, breast and AML).


News Articles [4600 Associated News Articles listed on BioPortfolio]

Evox Therapeutics raises new funds to support drug development

UK-based therapeutics developer Evox Therapeutics has secured $45.4m in a series B financing round to support new drug development. The...Read More... The post Evox Therapeutics raises new funds to su...

Sanofi signs $1bn drug development deal with Denali Therapeutics

Sanofi has entered a deal valued at more than $1bn with US-based Denali Therapeutics to advance potential drug candidates for...Read More... The post Sanofi signs $1bn drug development deal with Denal...

M&As this week: Nabriva Therapeutics, Sangamo Therapeutics, Ryboquin

Nabriva Therapeutics has completed the acquisition of Zavante Therapeutics for $97.5m. The acquisition will add the target company’s CONTEPO™ drug, which...Read More... The post M&As this we...

#jobs #lifescience Celgene: Scientist II, Translational Development (Myelofibrosis)

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Celgene: Scientist II, Translational Development (Myelofibrosis) . Celgene: O...

Renal Diseases Drug Development Pipeline Review: 2018 – Therapeutics Under Development and Key Players Involved – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Renal Diseases Drug Development Pipeline Review, 2018” report has been added to ResearchAndMarkets.com’s offering. Renal Diseases Drug Develop...

Mission Therapeutics Strengthens Clinical Development Team with Appointment of Dr Judit Molnar as Senior Director, Translational Medi

CAMBRIDGE, UK – 4 September 2018 – Mission Therapeutics (“Mission”), a drug discovery and development company focused on selectively targeting deubiquitylating enzymes (DU...

Boehringer and Domain Therapeutics form CNS drug discovery alliance

Boehringer Ingelheim has signed a drug discovery collaboration and licensing agreement with Domain Therapeutics for the development of new drugs...Read More... The post Boehringer and Domain Therapeut...

Abide Therapeutics starts Phase II trial of Tourette syndrome drug

Abide Therapeutics has started its Phase II clinical trial to examine the efficacy, safety, tolerability, and dosing regimen of ABX-1431...Read More... The post Abide Therapeutics starts Phase II tria...

PubMed Articles [5200 Associated PubMed Articles listed on BioPortfolio]

Translational in vitro research: integrating 3D drug discovery and development processes into the drug development pipeline.

As we witness steady progress towards the development of robust, scalable, and reproducible 3D tissue models for preclinical drug testing, there is a need for systematic physiological and pharmacologi...

Progress in Inherited Retinal Disease Drug Discovery and Development: A Foundation's Perspective.

Ophthalmic drug discovery and development has enjoyed a recent renaissance, with a major shift away from reformulating old systemic drugs for ocular use to de novo discovery of drugs for specific ocul...

The use of fast photochemical oxidation of proteins coupled with mass spectrometry in protein therapeutics discovery and development.

Structural analysis of protein therapeutics is a challenging task owing to complexities associated with large molecular size and 3D structures. Recent advances in fast photochemical oxidation of prote...

Recent US Food and Drug Administration Efforts to Integrate the Patient's Perspective in Drug Development and Decision Making.

Acceleration of rare disease therapeutic development: a case study of AGIL-AADC.

Rare-disease drug development is both scientifically and commercially challenging. This case study highlights Agilis Biotherapeutics (Agilis), a small private biotechnology company that has developed ...

Clinical Trials [4647 Associated Clinical Trials listed on BioPortfolio]

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

FS-1 Drug for Treatment of Multiple Drug-resistant Tuberculosis

Drug-resistant tuberculosis is becoming a major problem for the whole humanity, and development of new Anti-TB drugs is of great importance. Since Kazakhstan is a country with the high bur...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Companies [3973 Associated Companies listed on BioPortfolio]

Translational Drug Development (TD2) and Minneamrita Therapeutics LLC

Minneamrita is an early clinical stage drug development company developing the molecules for unmet cancer treatments. Minneamrita is developing Minnelide for its use in various ca...

Neurimmune Therapeutics AG

Neurimmune is a biopharmaceutical company dedicated to the development of immunotherapeutics for the treatment and prevention of human disorders with a focus on protein aggregation diseases. The cur...

Crown Bioscience, Inc.

Crown Bioscience, Inc. is a U.S.-based drug discovery service company with R&D facilities in China committed to advancing anti-cancer therapeutics through the preclinical a...

BlackThorn Therapeutics, Inc.

BlackThorn Therapeutics is a clinical-stage biopharmaceutical company dedicated to transforming the lives of people with neurobehavioral disorders through the discovery and develo...

TD2

Translational Drug Development (TD2) is an oncology development organization that provides innovative services for oncology-focused biopharmaceutical companies. Using a dedicated ...

More Information about "Translational Drug Development (TD2) and Minneamrita Therapeutics LLC" on BioPortfolio

We have published hundreds of Translational Drug Development (TD2) and Minneamrita Therapeutics LLC news stories on BioPortfolio along with dozens of Translational Drug Development (TD2) and Minneamrita Therapeutics LLC Clinical Trials and PubMed Articles about Translational Drug Development (TD2) and Minneamrita Therapeutics LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Translational Drug Development (TD2) and Minneamrita Therapeutics LLC Companies in our database. You can also find out about relevant Translational Drug Development (TD2) and Minneamrita Therapeutics LLC Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Pancreatitis
Pancreatitis Acute pancreatitis is inflammation of the pancreas caused by the release of activated pancreatic enzymes. Common triggers are biliary tract disease and chronic heavy alcohol intake.  Diagnosis is based on clinical presentation...


Corporate Database Quicklinks



Searches Linking to this Company Record